Ross Wallace

Ross Wallace is currently an Executive Director at Eli Lilly and Company, having previously held several senior roles within Loxo Oncology at Lilly, including Senior Director of ADME/DMPK. With over 13 years of experience in kinase drug discovery, Ross has led preclinical drug discovery programs and collaborated closely with medicinal chemistry to advance drug development. They have brought six drugs to the clinic, of which three were licensed to Loxo Oncology, and previously worked as a Research Scientist at Array BioPharma. Ross has extensive expertise in drug metabolism and pharmacokinetics, including the analysis of biological samples and modeling pharmacokinetic data.